GCIA
ALXN
Gabelli & Co Investment Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-189,497
| Closed | -$34.8M | – | 581 |
|
|
2021
Q2 | $34.8M | Buy |
189,497
+34,733
| +22% | +$6.38M | 4.02% | 3 |
|
|
2021
Q1 | $23.7M | Buy |
154,764
+112,214
| +264% | +$17.2M | 2.94% | 6 |
|
|
2020
Q4 | $6.65M | Buy |
+42,550
| New | +$6.65M | 1.04% | 24 |
|
|
2019
Q4 | – | Sell |
-2,250
| Closed | -$220K | – | 208 |
|
|
2019
Q3 | $220K | Buy |
+2,250
| New | +$220K | 0.02% | 153 |
|